Entering text into the input field will update the search result below

Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six...

Jul. 20, 2011 2:24 PM ETAbbott Laboratories (ABT) StockPJP, ABT, IHE, XPHBy: Clark Schultz, SA News Editor
Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six weeks ago when a study was released showing the medicine failed to prevent heart attacks. The firm told analysts on a conference call this morning the price of Niaspan was raised earlier this year, offsetting the decline in prescriptions.

Recommended For You

More Trending News

About ABT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ABT--
Abbott Laboratories
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.